Successfully reported this slideshow.

Asthma Guide for Management


Published on

  • D0WNL0AD FULL ▶ ▶ ▶ ▶ ◀ ◀ ◀ ◀
    Are you sure you want to  Yes  No
    Your message goes here

Asthma Guide for Management

  1. 1. By: Mohammed K. Abo Jalanbo, Intern Doctor, IUG School of Medicine
  2. 2. GINA was launched in 1993 in collaboration with the National Heart, Lung, and Blood Institute, National Institutes of Health, USA, and the World Health Organization. GINA Assembly members from 45 countries
  3. 3. WHAT IS KNOWN ABOUT ASTHMA DIAGNOSING ASTHMA COMPONENTS OF ASTHMA CARE Component 1. Develop Patient/Doctor Partnership Component 2. Identify and Reduce Exposure to Risk Factors Component 3. Assess, Treat, and Monitor Asthma Component 4. Manage Exacerbations Important Notes Special consideration
  4. 4. Asthma is chronic inflammatory disorder of large and small airways associated with hyperresponsivenes, reversible airflow limitation, and respiratory symptoms ,when airways are exposed to various risk factors. *Unfortunately…asthma is one of the most common chronic diseases, with an estimated 300 million individuals affected worldwide. Its prevalence is increasing, especially among children. *Fortunately… asthma can be effectively treated and most patients can achieve good control of their disease. *Asthma causes recurring episodes of wheezing, breathlessness, chest tightness, and coughing, particularly at night or in the early morning.
  5. 5. *Approximately 50% of cases develop prior to age 10; an additional 30% develop prior to age 40. *Although the majority of cases are diagnosed during childhood or early adulthood, new cases may be identified in patients as late as the 7th or 8th decade of life**. *Common risk factors for asthma symptoms include exposure to allergens (such as those from house dust mites, animals with fur, cockroaches, pollens, and molds), occupational irritants, tobacco smoke, respiratory (viral) infections, exercise, strong emotional expressions, chemical irritants, and drugs (such as aspirin and beta blockers).
  6. 6. Presence of any of these signs and symptoms should increase the suspicion of asthma: • Cough, worse particularly at night • Recurrent wheeze • Recurrent difficult breathing • Recurrent chest tightness Symptoms occur or worsen at night, awakening the patient. Symptoms occur or worsen in a seasonal pattern. The patient also has eczema, hay fever, or a family history of asthma or atopic diseases. Symptoms occur or worsen in the presence of triggering factors Symptoms respond to anti-asthma therapy. Patient’s colds “go to the chest” or take more than 10 days to clear up.
  7. 7. *Spirometry is the preferred method of measuring airflow limitation and its reversibility to establish a diagnosis of asthma. *An increase in FEV1 of ≥ 12% (or ≥ 200 ml) after administration of a bronchodilator indicates reversible airflow limitation consistent with asthma. (However, most asthma patients will not exhibit reversibility at each assessment, and repeated testing is advised.)
  8. 8. *Peak expiratory flow (PEF) measurements can be an important aid in both diagnosis and monitoring of asthma. * An improvement of 60 L/min (or 20% of the prebronchodilator PEF) after inhalation of a bronchodilator, or diurnal variation in PEF of more than 20% (with twice-daily readings, more than 10%), suggests a diagnosis of asthma.
  9. 9. *Additional diagnostic tests: For patients with symptoms consistent with asthma, but normal lung function, measurements of airway responsiveness to methacholine, histamine, mannitol, or exercise challenge may help establish a diagnosis of asthma. Skin tests with allergens or measurement of specific IgE in serum: The presence of allergies increases the probability of a diagnosis of asthma, and can help to identify risk factors that cause asthma symptoms in individual patients.
  10. 10. The goal of asthma care is to achieve and maintain control of the clinical manifestations of the disease for prolonged periods. When asthma is controlled, patients can prevent most attacks, avoid troublesome symptoms day and night, and keep physically active. To reach this goal, four interrelated components of therapy are required: Component 1. Develop patient/doctor partnership Component 2. Identify and reduce exposure to risk factors Component 3. Assess, treat, and monitor asthma Component 4. Manage asthma exacerbations
  11. 11. The first step in determining appropriate therapy for patients who are not already on a controller medication is classifying the severity of the patient's asthma. Assessment of "control," rather than severity, is used to adjust therapy in returning patients, or to alter therapy in patients already taking a long-term controller medication.
  12. 12. Each patient is assigned to one of five treatment “steps.” At each treatment step, reliever medication should be provided for quick relief of symptoms as needed. (However, be aware of how much reliever medication the patient is using—regular or increased use indicates that asthma is not well controlled.) At Steps 2 through 5, patients also require one or more regular controller medications, which keep symptoms and attacks from starting. Inhaled glucocorticosteroids are the most effective controller medications currently available. If asthma is not controlled on the current treatment regimen, treatment should be stepped up until control is achieved.
  13. 13. Typically, patients should be seen one to three months after the initial visit, and every three months thereafter. After an exacerbation, follow-up should be offered within two weeks to one month. *Adjusting medication: If asthma is not controlled on the current treatment regimen, step up treatment. Generally, improvement should be seen within 1 month. But first review the patient’s medication technique, compliance, and avoidance of risk factors. If asthma is partly controlled, consider stepping up treatment, depending on whether more effective options are available, safety and cost of possible treatment options, and the patient’s satisfaction with the level of control achieved. If control is maintained for at least 3 months, step down with a gradual, stepwise reduction in treatment. The goal is to decrease treatment to the least medication necessary to maintain control. *Monitoring is still necessary even after control is achieved, as asthma is a variable disease; treatment has to be adjusted periodically in response to loss of control as indicated by worsening symptoms or the development of an exacerbation.
  14. 14. 1) Assess the severity
  15. 15. *Combination 2-agonist/anticholinergic therapy is associated with lower hospitalization rates and greater improvement in PEF and FEV1. *Oral administration of prednisone has been shown to have effects equivalent to those of intravenous methylprednisolone. * Methylxanthines are not recommended if used in addition to high doses of inhaled 2-agonists. However, theophylline can be used if inhaled 2-agonists are not available. If the patient is already taking theophylline on a daily basis, serum concentration should be measured before adding short-acting theophylline. *Permissive hypercapnia” or “controlled hypoventilation” is the recommended ventilator strategy
  16. 16. *Therapies not recommended for treating asthma attacks include: •Sedatives (strictly avoid) • Mucolytic drugs (may worsen cough) • Chest physical therapy/physiotherapy (may increase patient discomfort) • Hydration with large volumes of fluid for adults and older children (may be necessary for younger children and infants) •Antibiotics (do not treat attacks but are indicated for patients who also have pneumonia or bacterial infection such as sinusitis) • Epinephrine/adrenaline (may be indicated for acute treatment of anaphylaxis and angioedema but is not indicated for asthma attacks)>>> there is no evidence to support the routine use of epinephrine for asthma exacerbations.
  17. 17. * *Pregnancy. During pregnancy the severity of asthma often changes, and patients may require close follow-up and advised that the greater risk to their baby lies with poorly controlled asthma. Acute exacerbations should be treated aggressively to avoid fetal hypoxia. * Surgery. Asthma predispose patients to intraoperative and postoperative respiratory complications, particularly with thoracic and upper abdominal surgeries. Lung function should be evaluated several days prior to surgery, and a brief course of glucocorticosteroids prescribed if FEV1 is less than 80% of the patient’s personal best.
  18. 18. *Rhinitis, Sinusitis, and Nasal Polyps. Both acute and chronic sinusitis can worsen asthma, and should be treated. Nasal polyps are associated with asthma and rhinitis, often with aspirin sensitivity and most frequently in adult patients. They are normally quite responsive to topical glucocorticosteroids. *Occupational asthma. Pharmacologic therapy for occupational asthma is identical to therapy for other forms of asthma, but is not a substitute for adequate avoidance of the relevant exposure. *Gastroesophageal reflux. GERD is nearly three times as prevalent in patients with asthma compared to the general population. Medical management should be given for the relief of reflux symptoms.